Literature DB >> 27301394

Postdischarge Bleeding After Percutaneous Coronary Intervention and Subsequent Mortality and Myocardial Infarction: Insights From the HMO Research Network-Stent Registry.

Javier A Valle1, Susan Shetterly2, Thomas M Maddox2, P Michael Ho2, Steven M Bradley2, Amneet Sandhu2, David Magid2, Thomas T Tsai2.   

Abstract

BACKGROUND: Bleeding after hospital discharge from percutaneous coronary intervention (PCI) is associated with increased risk of subsequent myocardial infarction (MI) and death; however, the timing of adverse events after these bleeding events is poorly understood. Defining this relationship may help clinicians identify critical periods when patients are at highest risk. METHODS AND
RESULTS: All patients undergoing PCI from 2004 to 2007 who survived to hospital discharge without a bleeding event were identified from the HMO Research Network-Stent (HMORN-Stent) Registry. Postdischarge rates and timing of bleeding-related hospitalizations, MI, and death were defined. We then assessed the association between postdischarge bleeding-related hospitalizations with death and MI using Cox proportional hazards models. Among 8137 post-PCI patients surviving to hospital discharge without in-hospital bleeding, 391 (4.8%) had bleeding-related hospitalization after discharge, with the highest incidence of bleeding-related hospitalizations occurring within 30 days of discharge (n=79, 20.2%). Postdischarge bleeding-related hospitalization after PCI was associated with subsequent death or MI (hazard ratio, 3.09; 95% confidence interval, 2.41-3.96), with the highest risk for death or MI occurring in the first 60 days after bleeding-related hospitalization (hazard ratio, 7.16; confidence interval, 3.93-13.05).
CONCLUSIONS: Approximately 1 in 20 post-PCI patients are readmitted for bleeding, with the highest incidence occurring within 30 days of discharge. Patients having postdischarge bleeding are at increased risk for subsequent death or MI, with the highest risk occurring within the first 60 days after a bleeding-related hospitalization. These findings suggest a critical period after bleeding events when patients are most vulnerable for further adverse events.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  hemorrhage; myocardial infarction; percutaneous coronary intervention; stent; survival

Mesh:

Year:  2016        PMID: 27301394      PMCID: PMC4922001          DOI: 10.1161/CIRCINTERVENTIONS.115.003519

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  33 in total

1.  Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials.

Authors:  D E Cutlip; D S Baim; K K Ho; J J Popma; A J Lansky; D J Cohen; J P Carrozza; M S Chauhan; O Rodriguez; R E Kuntz
Journal:  Circulation       Date:  2001-04-17       Impact factor: 29.690

2.  Impact of bleeding on subsequent early and late mortality after drug-eluting stent implantation.

Authors:  Young-Hak Kim; Jong-Young Lee; Jung-Min Ahn; Haegeun Song; Won-Jang Kim; Sung-Cheol Yun; Duk-Woo Park; Soo-Jin Kang; Seung-Whan Lee; Cheol Whan Lee; Seong-Wook Park; Seung-Jung Park
Journal:  JACC Cardiovasc Interv       Date:  2011-04       Impact factor: 11.195

3.  Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry.

Authors:  Sumeet Subherwal; Eric D Peterson; David Dai; Laine Thomas; John C Messenger; Ying Xian; Ralph G Brindis; Dmitriy N Feldman; Shaun Senter; Lloyd W Klein; Steven P Marso; Matthew T Roe; Sunil V Rao
Journal:  J Am Coll Cardiol       Date:  2012-05-22       Impact factor: 24.094

4.  Association of spontaneous bleeding and myocardial infarction with long-term mortality after percutaneous coronary intervention.

Authors:  Dhruv S Kazi; Thomas K Leong; Tara I Chang; Matthew D Solomon; Mark A Hlatky; Alan S Go
Journal:  J Am Coll Cardiol       Date:  2015-04-14       Impact factor: 24.094

5.  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

Authors:  Steven R Steinhubl; Peter B Berger; J Tift Mann; Edward T A Fry; Augustin DeLago; Charles Wilmer; Eric J Topol
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

6.  Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.

Authors:  Willem J M Dewilde; Tom Oirbans; Freek W A Verheugt; Johannes C Kelder; Bart J G L De Smet; Jean-Paul Herrman; Tom Adriaenssens; Mathias Vrolix; Antonius A C M Heestermans; Marije M Vis; Jan G P Tijsen; Arnoud W van 't Hof; Jurriën M ten Berg
Journal:  Lancet       Date:  2013-02-13       Impact factor: 79.321

Review 7.  The NCDR CathPCI Registry: a US national perspective on care and outcomes for percutaneous coronary intervention.

Authors:  Issam Moussa; Anthony Hermann; John C Messenger; Gregory J Dehmer; W Douglas Weaver; John S Rumsfeld; Frederick A Masoudi
Journal:  Heart       Date:  2013-01-15       Impact factor: 5.994

8.  Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.

Authors:  Eugenia Nikolsky; Gregg W Stone; Ajay J Kirtane; George D Dangas; Alexandra J Lansky; Brent McLaurin; A Michael Lincoff; Frederick Feit; Jeffrey W Moses; Martin Fahy; Steven V Manoukian; Harvey D White; E Magnus Ohman; Michel E Bertrand; David A Cox; Roxana Mehran
Journal:  J Am Coll Cardiol       Date:  2009-09-29       Impact factor: 24.094

9.  Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial.

Authors:  Steven V Manoukian; Frederick Feit; Roxana Mehran; Michele D Voeltz; Ramin Ebrahimi; Martial Hamon; George D Dangas; A Michael Lincoff; Harvey D White; Jeffrey W Moses; Spencer B King; E Magnus Ohman; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2007-03-09       Impact factor: 24.094

Review 10.  Standardized cardiovascular data for clinical research, registries, and patient care: a report from the Data Standards Workgroup of the National Cardiovascular Research Infrastructure project.

Authors:  H Vernon Anderson; William S Weintraub; Martha J Radford; Mark S Kremers; Matthew T Roe; Richard E Shaw; Dana M Pinchotti; James E Tcheng
Journal:  J Am Coll Cardiol       Date:  2013-03-06       Impact factor: 24.094

View more
  7 in total

1.  Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease.

Authors:  Ying-Chang Tung; Lai-Chu See; Shu-Hao Chang; Jia-Rou Liu; Chi-Tai Kuo; Chi-Jen Chang
Journal:  Sci Rep       Date:  2020-12-07       Impact factor: 4.379

2.  Trade-off of major bleeding versus myocardial infarction on mortality after percutaneous coronary intervention.

Authors:  Andrew Kei-Yan Ng; Pauline Yeung Ng; April Ip; Lap Tin Lam; Chung-Wah Siu
Journal:  Open Heart       Date:  2022-01

3.  Bilateral multifocal muscular hemorrhage in the triceps surae during antiplatelet therapy: a case report.

Authors:  Young-In Go; Gi-Wook Kim
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

4.  Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial.

Authors:  Pieter C Smits; Enrico Frigoli; Jan Tijssen; Peter Jüni; Pascal Vranckx; Yukio Ozaki; Marie-Claude Morice; Bernard Chevalier; Yoshinobu Onuma; Stephan Windecker; Pim A L Tonino; Marco Roffi; Maciej Lesiak; Felix Mahfoud; Jozef Bartunek; David Hildick-Smith; Antonio Colombo; Goran Stankovic; Andrés Iñiguez; Carl Schultz; Ran Kornowski; Paul J L Ong; Mirvat Alasnag; Alfredo E Rodriguez; Aris Moschovitis; Peep Laanmets; Dik Heg; Marco Valgimigli
Journal:  Circulation       Date:  2021-08-29       Impact factor: 29.690

5.  Clinical Characteristics and Long-Term Outcomes of Patients With Differing Haemoglobin Levels Undergoing Semi-Urgent and Elective Percutaneous Coronary Intervention in an Asian Population.

Authors:  Rodney Yu-Hang Soh; Ching-Hui Sia; Andie Hartanto Djohan; Rui-Huai Lau; Pei-Ying Ho; Jonathan Wen-Hui Neo; Jamie Sin-Ying Ho; Hui-Wen Sim; Tiong-Cheng Yeo; Huay-Cheem Tan; Mark Yan-Yee Chan; Joshua Ping-Yun Loh
Journal:  Front Cardiovasc Med       Date:  2022-03-18

6.  Bleeding After Hospital Discharge Following Acute Coronary Syndrome: Incidence, Types, Timing, and Predictors.

Authors:  Nafiu Ismail; Kelvin P Jordan; Umesh T Kadam; John J Edwards; Tim Kinnaird; Mamas A Mamas
Journal:  J Am Heart Assoc       Date:  2019-10-28       Impact factor: 5.501

7.  Long-term impact of baseline anaemia on clinical outcomes following percutaneous coronary intervention in stable angina.

Authors:  Line Davidsen; Kristian Hay Kragholm; Mette Aldahl; Christoffer Polcwiartek; Christian Torp-Pedersen; Peter Soegaard; Phillip Freeman
Journal:  Open Heart       Date:  2020-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.